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Summary
Vitamin D is widely reported to inhibit innate immune signalling and
dendritic cell (DC) maturation as a potential immunoregulatory mecha-
nism. It is not known whether vitamin D has global or gene-specific
effects on transcriptional responses downstream of innate immune stimu-
lation, or whether vitamin D inhibition of innate immune signalling is
common to different cells. We confirmed vitamin D inhibition of nuclear
factor-jB (NF-jB) and p38 mitogen-activated protein kinase (MAPK) sig-
nalling in monocyte-derived DC (MDDC) stimulated with lipopolysaccha-
ride (LPS). This was associated with global but modest attenuation of
LPS-induced transcriptional changes at genome-wide level. Surprisingly,
vitamin D did not inhibit innate immune NF-jB activation in monocyte-
derived macrophages. Consistent with our findings in MDDC, ex vivo
vitamin D treatment of primary peripheral blood myeloid DC also led to
significant inhibition of LPS-inducible NF-jB activation. Unexpectedly, in
the same samples, vitamin D enhanced activation of both NF-jB and
MAPK signalling in primary peripheral blood monocytes. In a cross-sec-
tional clinical cohort, we found no relationship between peripheral blood
vitamin D levels and LPS-inducible activation of NF-jB and MAPK path-
ways in monocytes of myeloid DC. Remarkably, however, in vivo supple-
mentation of people with vitamin D deficiency in this clinical cohort also
enhanced LPS-inducible MAPK signalling in peripheral blood monocytes.
Therefore, we report that vitamin D differentially modulates the molecu-
lar response to innate immune stimulation in monocytes, macrophages
and dendritic cells. These results are of importance in the design of stud-
ies on vitamin D supplementation in infectious and immunological
diseases.
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Introduction
Vitamin D deficiency is epidemiologically associated with
a wide range of autoimmune diseases. Consequently,
extensive research interest has focused on the role of vita-
min D in immune regulation and tolerance. Vitamin D is
synthesized as a pro-hormone from 7-dehydrocholesterol
in ultraviolet-B-irradiated skin followed by thermal iso-
merization, or is replenished by dietary intake, and
25-hydroxylated constitutively in the liver to form 25-
hydroxyvitamin D (25[OH]D).1 Further 1a-hydroxylation
is catalysed by the action of CYP27B1 to generate the
active moiety, 1,25[OH]D. Generation of 1,25[OH]D in
the kidney is a key step for endocrine regulation of cal-
cium homeostasis, but immune cells can also activate
vitamin D as a result of innate immune up-regulation of
CYP27B1, particularly by macrophages2 with downstream
autocrine and paracrine effects on diverse immune cells
that express the vitamin D receptor. A substantial body
of data show that 1,25[OH]D can regulate T-cell
responses either by inhibition of dendritic cell (DC) -
dependent T-cell activation or by induction of regulatory
T cells.3–6 Vitamin D inhibition of DC-dependent T-cell
activation has been primarily attributed to the inhibition
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of innate immune up-regulation of MHC class II and co-
stimulatory molecules such as interleukin-12 (IL-12) and
CD80/86, which are critical for activation of naive T
cells.3 The underlying mechanism for these effects of vita-
min D on the canonical function of DC remain poorly
understood, but the prevailing view is that 1,25[OH]D
attenuates innate immune intracellular signalling path-
ways. Ex vivo treatment of peripheral blood myeloid DC
with 1,25[OH]D is reported to inhibit lipopolysaccharide
(LPS) -induced activation of the classical nuclear factor-
jB (NF-jB) pathway,7 and ex vivo treatment of periph-
eral blood mononuclear cells (PBMC) with either 25
[OH]D or 1,25[OH]D has been reported to inhibit LPS-
induced activation of the mitogen-activated protein
kinase (MAPK) pathway in monocytes.8 Whether these
effects of vitamin D are also evident in vivo has not been
tested in human studies. We aimed to extend the existing
data on vitamin D modulation of innate immune cellular
activation by addressing two questions. First, given the
pivotal role of the NF-jB and MAPK pathways in initiat-
ing transcriptional responses to innate immune stimuli,
we sought to test whether vitamin D inhibited all such
responses or inhibited targeted genes selectively. Second,
in view of the interest in dietary vitamin D supplementa-
tion as a countermeasure to autoimmune diseases associ-
ated with vitamin D deficiency, we sought to test the
hypothesis in a clinical cohort that vitamin D deficiency
and in vivo vitamin D supplementation modulate innate
immune activation of peripheral blood monocytes and
myeloid DC consistent with the ex vivo studies described
above.
Methods
Innate immune stimulation of blood-derived cells
The study was approved by the joint University College
London/University College London Hospitals National
Health Service Trust Human Research Ethics Committee
(ref. 10/H0720/14). The PBMCs were obtained by
venepuncture of healthy volunteers and density-gradient
centrifugation. Monocyte-derived dendritic cells (MDDC)
were derived from magnetically sorted CD14-positive
monocytes differentiated in RPMI-1640 culture media
(Sigma, St Louis, MO) with 10% fetal calf serum, 100 ng/
ml granulocyte–macrophage colony-stimulating factor
(GM-CSF) and 50 ng/ml IL-4 for 4 days.2 Monocyte-
derived macrophages (MDM) were derived after adher-
ence to tissue-culture plastic and culture for 6 days in
RPMI-1640 with 10% autologous serum and 20 ng/ml
macrophage colony-stimulating factor (M-CSF).2 The
PBMC, MDDC and MDM were stimulated with either
100 ng/ml ultrapure LPS (Invivogen, San Diego, CA) as
Toll-like receptor 4 (TLR4) ligand, or with 1 lg/ml
Pam2CSK4 (PCSK, Invivogen) as a TLR2 ligand for
30 min to measure phosphorylation of p38 and NF-jB
p65 by flow cytometry, 60 min to undertake quantitative
confocal microscopy to evaluate nuclear translocation of
NF-jB p65, and 4 hr to measure transcriptional
responses.
Flow cytometry
Cells were stained with live/dead stain (Invitrogen, Carls-
bad, CA) before fixation in Fix I Buffer (BD Biosciences,
San Jose, CA) and immunostaining for cell surface CD14
(clone M5-E2) and CD11c (clone B-ly6) (BD Bio-
sciences). For intracellular markers, cells were permeabi-
lized with Perm/Wash buffer (BD Biosciences) before
staining with antibodies to phospho-NF-jB p65 (clone
20/NF-jB/p65) and phospho-p38 MAPK (clone 36/p38)
(BD Biosciences) as per the manufacturer’s instructions,
and analysed on an LSR-II flow cytometer (BD Bio-
sciences). The mean fluorescence intensity of staining of
each phospho-protein was used to calculate an activation
index represented by the ratio of stimulated to unstimu-
lated samples.
Transcriptional analysis by quantitative PCR and genome-
wide expression arrays
RNA samples were collected in RLT buffer and extracted
with the RNA Easy Kit (Qiagen, Hilden, Germany). All
samples were DNase (Ambion, Foster City, CA) treated
per the manufacturer’s instructions. For quantitative
PCR, first-strand cDNA was synthesized using the qScript
cDNA Supermix kit (QuantaBio, Beverley, MA). Real-
time quantitative RT-PCR (qPCR) of tumour necrosis
factor-a (TNF-a) (Hs00174128_m1), IL-1b (Hs01555410_m1)
and IL-6 (Hs00985639_m1) was performed with Taqman
primer probe sets (Applied Biosystems, Foster City, CA).
Expression levels of target genes were normalized to that
of glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
using established primer probe sets.9 Genome-wide
transcriptional profiling was performed using Agilent
microarrays as previously described.10,11 Principal compo-
nent analysis was used to compare global gene expression
profiles as previously described10 and paired t-tests with
Welch approximation and > 2-fold change filter were
used to identify significant gene expression differences
(P < 005) between groups using MULTIEXPERIMENT VIEWER
(v49). Transcription factor binding site enrichment anal-
ysis was performed using the human single site analysis
function in OPOSSUM.12 Upstream regulator analysis was
performed with Qiagen’s Ingenuity Pathway Analysis
(www.ingenuity.com/), filtering for molecule types to
include only genes, RNA and protein. Genes identified as
target molecules of p38 MAPK in this upstream analysis
were used as gene expression module for p38 MAPK
activity, and their geometric mean expression was defined
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as p38 module score. All microarray data used in this
study are available in ARRAYEXPRESS (https://www.ebi.ac.
uk/arrayexpress/) under the accession numbers E-TABM-
1206 and E-MTAB-4883.
Confocal microscopy
Nuclear : cytoplasmic ratios of NF-jB p65 were derived
from image analysis (METAMORPH v717, Molecular
Devices, Sunnyvale, CA) of confocal immunofluorescence
stains obtained with a spinning disc PerkinElmer Opera
LX microscope using rabbit polyclonal anti NF-jB RelA
(C-20) (Santa Cruz Biotechnology, Dallas, TX) and DAPI
staining as previously described.13 Cells were seeded into
96-well, optically clear-bottomed, tissue-culture-treated,
sterile Viewplate-96 (PerkinElmer, Waltham, MA, product
number 6005182) microplates. Olympus 40 9
LUCPLFLN (Numerical aperture = 06) air lens was used
to acquire images at two fluorescence channels using
365 nm and 561 nm excitation wavelengths, respectively.
Camera binning 2 was used, which resulted in a pixel size
of 0323 lm. Flatfield correction and skew-crop analysis
was performed for optical correction. To compensate the
systematic uneven brightness distribution of the optics, ref-
erence images were taken for flat-field correction. The
‘fish-eye effect’ and offset between channels were compen-
sated using bead images for skew-crop analysis. A standard
Opera Adjustment Plate (PerkinElmer, product number
HH10000650) was used for both flat field correction and
skew-crop analysis before image acquisition of each experi-
ment, following the manufacturer’s recommended proce-
dures. Twenty-five image fields were acquired, arranged in
a 5 9 5 sub-layout at the middle of each well.
In vivo vitamin D supplementation patient cohort
Adult patients, aged 16 years or over, were recruited from
the Endocrinology clinics at the Royal Free Hospital for
suspected or confirmed vitamin D deficiency, secondary
hyperparathyroidism, osteoporosis or osteopenia. The
study was approved by the UCL/UCLH/Royal Free
Biomedical Research Unit and an NHS Local Research
Ethics Committee (Reference: 10/H0720/14). Key exclu-
sion criteria were those taking any immunosuppressant or
immunomodulator drugs (e.g. carbimazole, methimazole,
glucocorticoids, antibiotics), those with currently active
infection, recent immunization within 1 month and,
pregnancy. Serum 25[OH]D levels were determined by
Roche Elecsys total Vitamin D immunoassay (Roche
Diagnostics, Burgess Hill, UK) which detects both 25
[OH] vitamins D3 and D2, and which has intra-assay CV
of 17–78% and inter-assay CV of < 22–131%. Where
patients were shown to have a 25[OH]D > 75 nM, no
supplementation was given. Where patients were shown
to have a 25[OH]D ≤ 75 nM, they were treated with
Colecalciferol (vitamin D3) for 3 months at a dose of
1000–2000 iu/day according to the treating physician’s
discretion before re-assessment of 25[OH]D levels. Pre-
and post-supplementation blood samples were taken
3 months apart. PBMC were isolated from BD Vacu-
tainer CPTTM Cell Preparation Tubes and cryopreserved
for batch testing. Pre- and post-supplementation samples
were assessed in the same batch. Thawed PBMCs were
washed and stimulated with LPS or PCSK for 30 min and
stained for flow cytometry as described above.
Results
Vitamin D inhibition of innate immune responses in
MDDC
Peripheral blood monocytes differentiated with IL-4 and
GM-CSF for 4 days have been extensively used as an
experimental model for myeloid DC,2 which respond to
innate immune stimulation with widespread transcrip-
tional changes involving both NF-jB and MAPK sig-
nalling pathways. Consistent with the existing literature,7,8
we found that MDDC differentiated in the presence of
1,25[OH]D showed attenuated phosphorylation of NF-jB
p65 and MAPK p38 in response to 30 min innate
immune stimulation of TLR4 with LPS, or TLR2 with
PCSK (Fig. 1a). Previous reports have suggested that this
effect of vitamin D may underpin attenuated up-regula-
tion of T-cell co-stimulatory molecule expression by
MDDC in response to innate immune stimulation and
consequently contribute to vitamin D inhibition of DC-
mediated T-cell activation.7 Counterintuitively, a recent
report suggests that vitamin D preconditioning enhanced
the expression of canonical pro-inflammatory cytokines,
such as TNF-a, IL-1b and IL-6 following innate immune
stimulation of MDDC with LPS for 4 hr.14 We observed
that MDDC differentiation in the presence of 1,25[OH]D
down-regulated basal level expression of TNF-a selec-
tively, but transcription of all three cytokines was robustly
up-regulated in response to LPS stimulation. The only
significant difference attributable to vitamin D was mod-
est attenuation of IL-6 transcriptional up-regulation
(Fig. 1b). In view of the fact that innate immune stimuli
generate widespread transcriptional changes in DC,15 we
extended this analysis to genome-wide transcriptomes of
MDDC differentiated in the presence and absence of 1,25
[OH]D, with or without 4 hr LPS stimulation. We also
compared these to the transcriptomes of monocytes from
which the MDDC were derived. Principal component
analysis (PCA) of these data showed transcriptomic
changes in principal component 2 (PC2), attributable to
differentiation of monocytes to MDDC and the effects of
vitamin D, and independent changes in PC1 attributable
to LPS stimulation (Fig. 2a). We concluded from this
analysis that monocyte differentiation in response to GM-
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CSF and IL-4 is preserved in the presence of vitamin D
consistent with another previous report.16 Interestingly,
MDDC differentiated in the presence of 1,25[OH]D
exhibited quantitatively smaller transcriptomic differences
attributed to LPS stimulation in PC2, suggesting some
attenuation of the response to LPS. Comparison of fold
changes in gene expression following LPS stimulation,
similarly showed narrowing of the frequency distribution
in MDDC differentiated in the presence of 1,25[OH]D
(Fig. 2b), suggesting that the range of LPS-induced tran-
scriptional changes is quantitatively attenuated by vitamin
D This effect is shown in LPS up-regulated genes specifi-
cally, at the level of individual genes (Fig. 2c, and see
Supplementary material, Data S1), and by making gen-
ome-wide comparison of quantitative fold changes in
LPS-inducible transcriptional changes, which gives a
regression slope of 05 (Fig. 2d), and suggests that at the
genome-wide level, 1,25[OH]D reduced the magnitude of
fold responses to LPS by half. In this analysis the r2 cor-
relation coefficient also approximated to 05, giving a
measure of the gene-specific heterogeneity of 1,25[OH]D
attenuation in LPS responses.
Vitamin D attenuation of NF-jB and p38 MAPK-
dependent transcriptional responses to LPS
Transcription factor binding site enrichment analysis of
the genes up-regulated by LPS can be used to infer the
putative upstream transcriptional transactivator path-
ways.12 In control MDDC cells, this analysis was
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Figure 1. (a) Flow cytometry histograms of phospho-nuclear factor-jB (NFjB) p65 or phospho-p38 mitogen-activated protein kinase (MAPK)
and (b) relative transcript abundance of the pro-inflammatory cytokines indicated, in monocyte-derived dendritic cells (MDDC) differentiated in
the presence and absence of 100 nM 1,25[OH]D with and without stimulation of Toll-like receptor 4 (TLR4) (LPS) or TLR2 (Pam2CSK4) on day
four. n = 3 per group. Bars represent mean  SEM. *P < 005 by t-test.
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Figure 2. (a) Principal components analysis of
genome-wide transcriptomes of monocytes and
monocyte-derived dendritic cells (MDDC) dif-
ferentiated in the presence or absence of
100 nM 1,25[OH]D with or without 4 hr of
lipopolysaccharide (LPS) stimulation on day 4
(n = 3–8 per group. Data points represent
mean  SEM). (b) Frequency distribution of
mean fold changes in transcript abundance, (c)
heat map of mean gene expression in LPS up-
regulated genes in MDDC differentiated in the
presence or absence of 100 nM 1,25[OH]D and
(d) comparison of gene specific mean fold
changes in response to 4 hr of LPS stimulation
in MDDC differentiated in the presence or
absence of 100 nM 1,25[OH]D.
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consistent with the predominant role of NF-jB pathways
in LPS responses (Fig. 3a). The NF-jB transcription fac-
tor binding sites were also the most enriched in LPS
responses by MDDC differentiated in the presence of 1,25
[OH]D. In keeping with vitamin D inhibition of LPS-
induced NF-jB activation and the attenuation of tran-
scriptional responses, statistical enrichment of NF-jB
transcription factor binding sites in the list of LPS-induci-
ble genes was also lower in 1,25[OH]D-exposed MDDC.
Assessment of the effect of vitaminD on MAPK p38-
dependent transcriptional responses by transcription fac-
tor binding site enrichment analysis was not possible
because the MAPK pathway affects multiple downstream
transcription factors. Instead we undertook a different
bioinformatics approach using Ingenuity Pathway Analy-
sis to show that MAPK p38 was predicted as an upstream
regulator of LPS-stimulated transcriptional responses in
control DC (Fig. 3b). We then used the genes associated
with p38 MAPK as an upstream regulator in this analysis
to represent a gene expression module for p38 MAPK
activity. The geometric mean expression of this module
was significantly attenuated in MDDC differentiated in
the presence of 1,25[OH]D (Fig. 3c) consistent with the
hypothesis that vitamin D attenuated the activity of this
pathway also.
Differential effects of vitamin D on innate immune
activation in myeloid cell subsets
Next, we sought to test the hypothesis that vitamin D
inhibition of innate immune signalling pathways, which
are evident in MDDC, are also observed in MDM, and in
circulating blood monocytes and myeloid DC.
The MDM were differentiated with M-CSF in the pres-
ence and absence of 1,25[OH]D for 6 days as previously
described.2 Canonical NF-jB pathway activation in
response to LPS or PCSK was then assessed in this model
using a well-established microscopy assay to quantify
nuclear translocation of NF-jB p65.13,17,18 These cells
showed a clear dose response to both stimuli but no
attenuation of NF-jB activation in MDM exposed to
vitamin D (Fig. 4a,b).
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Figure 3. (a) Statistical enrichment (Z score)
of transcription factor binding sites among
genes up-regulated by 4 hr of lipopolysaccha-
ride (LPS) stimulation in monocyte-derived
dendritic cells (MDDC) differentiated in the
absence or presence of 100 nM 1,25[OH]D
(n = 3 per group). (b) Activation Z-scores for
upstream regulators of LPS up-regulated genes
in control MDDC after 4 hr of LPS stimula-
tion. The dashed line denotes a Z-score of 2,
above which a regulator is predicted to be acti-
vated statistically. (c) Module score represent-
ing p38 mitogen-activated protein kinase
(MAPK) activity in control and 1,25[OH]D-
treated (1,25D) MDDC with or without 4 hr
of LPS stimulation, derived from the geometric
mean expression of genes that were identified
as targets of p38 in the upstream analysis in
(b). n = 3 in each group. Bars represent
mean  SEM. *P < 005 by t-test.
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To investigate the effect of vitamin D on peripheral
blood monocytes and myeloid DC, PBMC were incu-
bated with 1,25[OH]D overnight before stimulation with
LPS for 30 min. An activation index for NF-jB and
MAPK pathways was then quantified by flow cytometric
comparison of phosphorylated (p)-NF-jB p65 or p-p38
MAPK in stimulated and unstimulated cells identified
by light scatter properties and immunostaining for
CD11c and CD14 (Fig. 4c), where monocytes were
identified as CD14hi CD11hi and circulating myeloid DC
as CD14lo CD11chi. In this analysis, we detected
increased NF-jB p65 phosphorylation, but no increase
in p38 MAPK phosphorylation in myeloid DC following
stimulation with LPS. The NF-jB response was inhib-
ited in peripheral blood myeloid DC after overnight
exposure to 1,25[OH]D (Fig. 4d,e), consistent with the
inhibitory effect of vitamin D on innate immune stimu-
lation of MDDC. In contrast, phosphorylation of both
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Figure 4. (a) Representative images of mono-
cyte-derived macrophages (MDM) stained with
DAPI or antibody to nuclear factor-jB (NF-
jB) p65 and (b) summary data from > 500
single cell measurements of nuclear : cytoplas-
mic ratios of NF-jB p65 staining in MDM dif-
ferentiated in the presence and absence of
100 nM 1,25[OH]D following 60 min of stimu-
lation with increasing concentrations of
lipopolysaccharide (LPS) or Pam2CSK4. Bars
represent mean  SEM. (c) Representative
flow cytomeytric dot plots to show gating
strategy for identification of myeloid cells on
the basis of light scatter and then monocytes
and myeloid dendritic cells (DC) on the basis
of CD11c and CD14 immunostaining. (d) Rep-
resentative histograms of flow cytometric mea-
surement of cell-type-specific phospho-NF-
jB p65 or p38 mitogen-activated protein
kinase (MAPK) staining in peripheral blood
mononuclear cells (PBMC) with and without
30 min of LPS stimulation. (e) Summary data
for activation of NF-jB and MAPK pathways
measured by ratio of phospho-protein staining
in stimulated to unstimulated cells, in PBMC
with (grey bars) and without (white bars) prior
overnight incubation with 100 nM 1,25[OH]D
(1,25D). n = 5 per group. Bars represent
mean  SEM. *P < 005 by t-test.
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NF-jB p65 and p38 MAPK was significantly enhanced
in peripheral blood monocytes exposed to 1,25[OH]D
(Fig. 4d,e). Hence pre-incubation with vitamin D had
the opposite effect on innate immune response sig-
nalling in blood monocytes and myeloid DC.
Opposing effects of in vivo vitamin D
supplementation in peripheral blood monocytes and
myeloid DC
The opposing effects of ex vivo exposure of circulating
blood monocytes and myeloid DC to 1,25[OH]D has not
previously been reported. Therefore, we sought to validate
and extend these observations in a more physiological
context, by testing the hypothesis that vitamin D levels
in vivo also show positive correlation with enhanced
innate immune signalling in monocytes and attenuated
signalling in circulating myeloid DC. Circulating 1,25
[OH]D is predominantly protein-bound and the total
levels do not accurately reflect total vitamin D levels
in vivo. Instead, circulating levels of the precursor, 25
[OH]D, are more commonly used as a measure of vita-
min D levels in blood. In a cross-sectional study of
patients subjected to vitamin D testing, we found no
correlations between variation in serum 25[OH]D levels
and variation in innate immune activation indices for
phosphorylation of NF-jB p65 or p38 MAPK in mono-
cytes or myeloid DC within ex vivo PBMC stimulated
with LPS (Fig. 5a).
Patients with serum 25[OH]D levels below 25 nM
(10 ng/ml) are considered deficient, and vitamin D sup-
plementation is mandated in this group. Those with levels
between 25 and 75 nM (10–30 ng/ml) are considered vita-
min D insufficient, with supplementation optional
depending on the patient’s co-morbidities and symptoms.
The aim of supplementation is to achieve levels of
> 75 nM (30 ng/ml), according to published guidelines.19
Vitamin D supplementation in this context, therefore
provided an opportunity to assess the effect of vitamin D
on innate immune signalling in monocytes and circulat-
ing myeloid DC in samples obtained before and after suc-
cessful oral supplementation. For this, we recruited adults
with vitamin D deficiency. We first tested innate immune
responses in PBMC from patients in whom pre-supple-
mentation 25[OH]D levels were < 25 nM, representing
vitamin D deficiency. All of these patients showed
increased 25[OH]D levels after vitamin D3 supplementa-
tion. In keeping with our results from in vitro incubation
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Figure 5. (a) Cross-sectional relationship
between activation index for phosphorylation
of nuclear factor-jB (NF-jB) p65 and p38 mi-
togen-activated protein kinase (MAPK) within
monocytes and myeloid dendritic cells (DC) in
peripheral blood mononuclear cells (PBMC)
stimulated with lipopolysaccharide (LPS), and
serum levels of 25[OH]D (25D). All correla-
tion coefficients P > 005. (b) Serum 25[OH]D
levels before and after oral vitamin D supple-
mentation in subjects with < 25 nM (n = 8) or
≥ 25 nM (n = 18) pre-supplementation. Paired
data points shown for each subject. NS denotes
non-significance, *P = 0008 and **P = 0002
by Wilcoxon signed rank test. (c) Activation
index for phosphorylation of NF-jB p65 and
p38 MAPK within monocytes and myeloid DC
in PBMC stimulated with LPS [Toll-like recep-
tor 4 (TLR4)] or Pam2CSK4 (TLR2) before
and after oral vitamin D3 supplementation in
deficient subjects with < 25 nM or (d) insuffi-
cient subjects with 25–75 nM pre-supplementa-
tion. n = 8 per group. Bars represent
mean  SEM. *P < 005 by t-test.
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of PBMC to 1,25[OH]D, we found that successful in vivo
supplementation with vitamin D3 in this group was asso-
ciated with enhanced LPS-induced phosphorylation of
p38 MAPK in monocytes, but we found no significant
effects on LPS-induced phosphorylation of NF-jB p65 in
monocytes, or on either signalling event in circulating
myeloid DC (Fig. 5c). We also tested patients in whom
pre-supplementation 25[OH]D levels were > 25 nM. In
this group, we found no differences in the target NF-jB
or MAPK signalling events in either the monocytes or
myeloid DC within PBMC (Fig. 5d), suggesting that an
effect of vitamin D supplementation is only detectable in
those with vitamin D deficiency (< 25 nM) before receiv-
ing oral supplements.
Discussion
Vitamin D has been consistently shown to inhibit matu-
ration of MDDC following innate immune stimulation
and consequently their ability to activate T cells. We have
confirmed that vitamin D inhibits NF-jB and MAPK sig-
nalling in MDDC following innate immune stimulation.
This was associated with a global attenuation of LPS-
induced transcriptional responses. We could not replicate
a previous report that pro-inflammatory innate immune
responses were augmented by vitamin D.14 The inhibitory
effects of in vitro vitamin D treatment on innate immune
signalling was reproduced in primary peripheral blood
myeloid DC, but not in monocytes within the same
PBMC samples or in MDM. In fact, we observed
increased innate immune activation of both NF-jB and
MAPK pathways in monocytes within PBMC following
in vitro incubation with vitamin D. At face value, this
observation also contrasts with a previous report that
in vitro incubation of monocytes with vitamin D does
inhibit innate immune signalling and transcriptional
responses, possibly as a result of down-regulated expres-
sion of innate immune receptors such as TLR2 and
TLR4.20 Interestingly, however, the effect of vitamin D in
this earlier report was most evident with increasing time
in culture, raising the possibility that the observations
may have been confounded by in vitro cellular differentia-
tion of the monocytes in culture. Further paired assess-
ments of peripheral blood monocytes and myeloid DC
from vitamin D-deficient subjects before and after oral
vitamin D3 supplementation provided a unique opportu-
nity to assess in vivo modulation of innate immune acti-
vation pathways by vitamin D. In these experiments, we
found increased innate immune activation of the MAPK
pathway in monocytes, but no effect on NF-jB activation
and no effect in peripheral blood myeloid DC. These
effects were specific to the subgroup of patients with
baseline 25[OH]D levels < 25 nM and not evident in
those with baseline 25[OH]D levels of 25-75 nM, suggest-
ing that vitamin D supplementation to modulate innate
immune signalling may only be effective in people with
severe deficiency.
Taken together, we conclude that although vitamin D
undoubtedly can modulate innate immune activation
pathways in myeloid cells, its effects are highly
cell-specific. Most importantly, our data highlight that
translational applications in which vitamin D supplemen-
tation is being suggested on the basis of the existing liter-
ature in DC, may actually cause the opposite effect,
particularly in diseases in which monocytes or macro-
phages play a dominant role. Further, immunological
assessments before and after vitamin D supplementation
are needed to inform context-specific immunomodulatory
interventions with vitamin D specifically targeting those
with pre-existing deficiency with baseline levels < 25 nM.
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